I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

*Burkholderia pseudomallei* is a Gram-negative saprophytic soil β-proteobacterium that causes melioidosis, a severe disease of humans and animals. Melioidosis is endemic in a number of areas of Southeast Asia, Northern Australia, the Pacific, Central and South America, and the Caribbean.\[[@ref1]\] According to recent estimates, the global burden of melioidosis is about 165,000 human cases per year, and an infection is probably endemic in at least 79 countries.\[[@ref2]\]

Melioidosis is acquired more often through contact with contaminated soil and water by percutaneous inoculation. The human cases are often spatially and temporally clustered, following the severe weather events such as heavy rains and flooding.\[[@ref3]\] Clinical manifestation of melioidosis varies widely from asymptomatic disease to rapidly progressive pneumonia and sepsis. The symptoms often are very similar to other both infectious and non-infectious diseases-tuberculosis, mycosis, sarcoidosis, cancer, which makes the differential clinical diagnosis of melioidosis quite a challenge.\[[@ref4][@ref5]\] Treatment of melioidosis is hampered by an intrinsic resistance of *B. pseudomallei* to various antimicrobials.\[[@ref3][@ref6]\]

The correct laboratory diagnosis of melioidosis is essential for a favorable outcome but can be difficult. *B. pseudomallei* is usually poorly isolated from clinical specimens and may not be correctly identified when isolated.\[[@ref5][@ref7]\] Routinely used serological tests generally are not sufficiently specific or sensitive. Although laboratory diagnosis of melioidosis has advanced using of more sensitive and rapid tests such as polymerase chain reaction (PCR), DNA sequencing, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry,\[[@ref8]\] the correct identification of *B. pseudomallei* isolates through conventional bacteriologic scheme is very important, especially in clinical microbiology laboratories in nonendemic areas where clinical suspicion is insufficient.

Due to duration and complexity of routine bacteriological identification of *B. pseudomallei*,\[[@ref5][@ref6]\] the suitability of various commercial biochemical tests has been studied for a long time. As has been noted repeatedly, the currently available biochemical systems can misidentify some strains of *B. pseudomallei* as *Chromobacterium violaceum* or *Burkholderia cepacia* complex.\[[@ref7][@ref9][@ref10][@ref11][@ref12]\] A particular problem is associated with misidentification of *B. pseudomallei* as *B. cepacia* by Vitek 2 analyzer (bioMérieux) widely used in clinical microbiology laboratories.\[[@ref12][@ref13]\]

The aim of this study was to identify the biochemical features, which can cause an incorrect identification of *B. pseudomallei* by Vitek 2 system.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

Strains, culture condition, and identification on Vitek 2 platform {#sec2-1}
------------------------------------------------------------------

Forty strains of *B. pseudomallei* studied in this work are listed in [Table 1](#T1){ref-type="table"}. All strains were confirmed by specific PCR, DNA sequencing, and conventional bacteriologic method. The strains were subcultured on LB agar (HiMedia Laboratories Pvt. Ltd, India) for 24 hours at 37°C before testing on Vitek 2. The GN cards (bioMérieux) were used for analysis according to the manufacturer\'s instructions.

###### 

Identification of *Burkholderia pseudomallei* strains by Vitek 2 and nonmetric multidimensional scaling clustering of biochemical profiles
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Comparative analysis of biochemical profiles {#sec2-2}
--------------------------------------------

The comparative analysis of binary biochemical profiles (0-lack of the feature, 1-positive) was carried using PRIMER package version 7.0.10 (Primer-E Ltd., Plymouth Marine Laboratory, United Kingdom). The clustering of the strains was performed using nonmetric multidimensional scaling (nMDS) on Euclidean distances similarity matrix of biochemical profiles. The reliability of biochemical patterns difference between properly and incorrectly identified strains was assessed using nonparametric analysis of similarity (ANOSIM). The ANOSIM percentage was used to evaluate an average contribution of each biochemical test in overall dissimilarity between clusters.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Biochemical identification {#sec2-3}
--------------------------

The most of studied *B. pseudomallei* strains (77.5% of the total) were identified correctly with the reliability of 90%--99% \[[Table 1](#T1){ref-type="table"}\]. Five strains (12.5%) were identified at low discrimination as *B. cepacia* complex/*B. pseudomallei* with the recommendation to use additional differentiating tests. Four strains (10%) were identified as *B. cepacia* complex with the conclusion "very good identification" (1 strain) and "excellent identification" (3 strains).

Nonmetric multidimensional scaling analysis {#sec2-4}
-------------------------------------------

The nMDS allowed to group the strains of *B. pseudomallei* into 8 clusters \[[Figure 1](#F1){ref-type="fig"}\]. The clusters A, F, E, and G included one strain each. Three strains identified incorrectly as *B. cepacia* and one correctly identified strain ("excellent identification") were included in cluster B. Thirteen strains with high probability of identification (97%--99%) were combined in cluster C. The cluster H proved to be the most extensive, which included 11 strains with "excellent identification," 2 strains with "good identification," and 2 strains at low discrimination. The cluster D includes 4 strains, of which 3 are at low discrimination and 1-with a high probability of identification (93%) \[[Table 1](#T1){ref-type="table"}\].

![Nonmetric multidimensional scaling ordination on the euclidean distance similarity matrix of the Vitek 2 biochemical profile of 40 *Burkholderia pseudomallei* strains identified as *Burkholderia pseudomallei* and misidentified as *Burkholderia cepacia*, or strains at low discrimination](JGID-10-7-g002){#F1}

The contribution of individual biochemical tests in misidentification of *Burkholderia pseudomallei* {#sec2-5}
----------------------------------------------------------------------------------------------------

The ANOSIM showed statistically significant differences in biochemical patterns of correctly and incorrectly identified strains (*R* statistic of 0.836, *P* = 0.001). The results estimate the average contribution of biochemical tests in overall dissimilarity between biochemical profile clusters are shown in [Table 2](#T2){ref-type="table"}.

###### 

The average contribution of selected biochemical tests in overall dissimilarity between clusters of the strains
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It seems clear that the reliability of identification decreased in case of absence of phosphatase (PHOS), β-N-acetyl glucosaminidase (BNAG), N-acetyl galactosaminidase (NAGA) and the presence of D-cellobiase (dCEL), L-proline arylamidase (ProA), and tyrosine arylamidase (TyrA) activities. Thus, in strains identified at low discrimination, the dCEL and TyrA tests were positive in 100% of cases, and ProA in 80% of cases. At the same time, the NAGA (80% of cases), BNAG, and PHOS (60% of cases) tests were negative \[[Table 2](#T2){ref-type="table"}\].

The comparison of biochemical profiles included in cluster B (*B. pseudomallei* 2 identified with the reliability of 97%, and *B. pseudomallei* 130, 138, and 60839 misidentified as *B. cepacia*) showed positive dCEL and negative PHOS in all cases. The BNAG test was negative in only one (*B. pseudomallei* 138) of the three wrongly identified strains \[[Table 3](#T3){ref-type="table"}\]. The glutamyl arylamidase Pna, D-maltose, D-mannitol (dMAN), D-sorbitol (dSOR), citrate, and malonate utilization tests also varied, but any consistent patterns affecting identification have not been revealed in these cases. The key tests in this cluster were ProA and TyrA, which were positive in correctly identified strain, similar to 58% and 64.5% of all correctly identified strains, respectively, whereas all misidentified strains were negative for these biochemical features \[[Table 2](#T2){ref-type="table"}\].

###### 

The biochemical tests varied in strains constituting cluster B
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D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

The troubles on the correct identification of *B. pseudomallei* by various biochemical systems have been described repeatedly. According to different data, the reliability of API 20NE (bioMérieux) manual system for identification of *B. pseudomallei* varied significantly,\[[@ref7][@ref9][@ref10][@ref14]\] that, combined with a long operating time, not allows to consider this system as the best option for *B. pseudomallei* identification.

A part of various automated systems does not include a representative set of biochemical profiles for *B. pseudomallei*,\[[@ref15]\] whereas others give mainly low discrimination for *B. pseudomallei* or misidentification as *B. cepacia*.\[[@ref9]\]

Widely used Vitek 2 system gives the most stable identification results, especially with the use of colorimetric-based GN cards.\[[@ref16]\] Nevertheless, the identification accuracy still varies considerably for *B. pseudomallei* strains of different geographical origin.\[[@ref11]\] An important task is to establish exactly what biochemical tests due to its variability lead to misidentification or low discrimination of *B. pseudomallei*.

As revealed by Lowe *et al*., the uncertain results of several biochemical tests (D-cellobiose, D-glucose, dMAN, dSOR, gamma-glutamyltransferase, L-lysine arylamidase, and phosphatase) would result in a reduction of Vitek 2 discriminating ability for *B. pseudomallei*.\[[@ref10]\] More recently, Podin *et al*. noted that in particular, two enzymatic tests, BNAG and NAGA, were distinct between correctly and misidentified *B. pseudomallei* isolates.\[[@ref11]\]

The results of the present study showed that a set of negative NAGA, BNAG, PHOS and positive dCEL, TyrA, ProA tests lead to low discrimination of *B. pseudomallei*, and the presence of dCEL activity combined with negative tests for NAGA, TyrA, and ProA would result in misidentification of *B. pseudomallei* as *B. cepacia* complex.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

The obtained results demonstrate the effect of the variability of several biochemical features on the accuracy of *B. pseudomallei* identification. The data mentioned above demonstrate the need of further expansion of the Vitek 2 identification keys for atypical or regionally distributed biochemical profiles of *B. pseudomallei*. Also important, that clinicians and diagnostic laboratories stuff should be aware on the possibility of misidentification of *B. pseudomallei* as *B. cepacia* using automated biochemical identification systems.
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